Red Tortoise LLC’s Medifast MED Stock Holding History

Red Tortoise LLC’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-218	Closed	-$2.98K	–	618
2025 Q3	$2.98K	Hold	218	–	–	﹤0.01%	474
2025 Q2	$3.06K	Buy	218 +85	+64%	+$1.12K	﹤0.01%	448
2025 Q1	$1.79K	Buy	+133	New	+$2K	﹤0.01%	529

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Red Tortoise LLC's MED Position: Q4 2025 in Review

Red Tortoise LLC sold out of Medifast (MED) in Q4 2025, closing a stake of 218 shares — an estimated $2.98K sold.

Red Tortoise LLC first reported a position in MED in Q1 2025 and held it in 3 quarters. The position peaked at $3.06K in Q2 2025. 109 funds tracked by Wall St. Rank hold MED as of Q4 2025.

Red Tortoise LLC reported no remaining Medifast position as of Q4 2025 after selling out during the quarter.
Red Tortoise LLC sold 218 Medifast shares in Q4 2025, an estimated $2.98K.
Red Tortoise LLC first reported a position in Medifast in Q1 2025 and held it in 3 quarters.
Red Tortoise LLC's Medifast position peaked at $3.06K in Q2 2025.
109 funds tracked by Wall St. Rank held Medifast as of Q4 2025.

Based on Red Tortoise LLC's 13F filing for Q4 2025, filed 22 Jan 2026.